The Challenge: Rapidly Shifting Bioprocesses Outpace Traditional Analytics and Monitoring
Biomanufacturing relies on living systems, and living systems can change fast. Cell health, productivity, and functional performance shift in response to stress, infection or transfection events, media changes, or subtle upstream variation. Yet most in‑process monitoring tools rely on slow, label‑dependent, or low‑resolution assays that:
- Provide delayed or incomplete readouts
- Mask population heterogeneity
- Miss early indicators of stress or contamination
- Offer limited predictive value for yield or product quality
As processes become more complex — especially in viral vector production, cell therapy, gene therapy, and vaccine development — these blind spots introduce risk, variability, and unnecessary cost. Teams need real‑time, mechanism‑relevant analytics that reveal what’s happening inside their cultures as it happens, not after the fact.
Speak to an Expert
How LumaCyte Helps: Real‑Time, Holistic, Label-Free Data Insights with Laser Force Cytology™
Radiance®, powered by Laser Force Cytology™ (LFC), delivers label‑free, single‑cell analytics that quantify intrinsic biochemical and biophysical properties — including optical force response, deformability, and whole‑cell vitality signatures — in minutes. These measurements correlate directly with functional performance, giving teams a real‑time window into cellular behavior without dyes, stains, or reporters.
With Radiance®, developers can:
- Detect early phenotypic fingerprint shifts to anticipate process drift before it affects performance.
- Monitor infection, activation, transfection, or differentiation events to optimize timing and maximize productivity.
- Identify stress‑related declines early enough to protect yield and prevent downstream failures.
- Track culture performance continuously or at‑line to maintain tighter control over critical process parameters.
- Make faster, more confident process adjustments that stabilize runs and reduce variability.
Because Radiance® is label‑free and requires minimal sample prep, it integrates easily into existing workflows — from early development through scale‑up and GMP manufacturing — without adding operational complexity. Through its holistic data insights, Radiance® supports stronger process understanding, aligning with modern regulatory expectations for advanced cellular PAT‑enabled bioprocess monitoring.
Why It Matters: Earlier Insight, Stronger Control, Better Patient Outcomes
Radiance® gives teams the clarity and speed needed to stabilize complex bioprocesses, protect yield, reduce COGS, and ensure the consistent production of high‑quality advanced biologics and ATMPs. With holistic, real‑time, label-free data insights, developers can:
- Detect early functional and phenotypic shifts in both starting material and in‑process cultures to prevent downstream failures and safeguard product quality.
- Improve batch‑to‑batch consistency to deliver more reliable therapies and reduce manufacturing variability.
- Increase productivity and yield by optimizing critical process decisions at the right moment.
- Reduce the risk of batch failure, protecting timelines, resources, and patient access to life‑changing treatments.
- Lower COGS by minimizing rework, reducing failed runs, and enabling more efficient, data‑driven process control.
- Strengthen alignment with PAT frameworks and regulatory expectations to support robust, scalable manufacturing.
These advantages are essential for advanced biologics and ATMP manufacturing, where every decision influences product quality — and ultimately, the safety, efficacy, and availability of therapies for patients.
Speak to an Expert
Process Monitoring Using Laser Force Cytology™
Radiance® provides real-time data for cell health conditions, characterizing changes and ensuring consistent process performance.
Contamination can be detected quickly, allowing for improved process and quality controls.
Cellular changes as a result of bacterial contamination are distinct from other events such as transfection and transduction.
Rapid Detection of Out-of-Spec (OOS) Batches
In Process Manufacturing Application
Radiance® data can be used to monitor production runs in real time to understand the expected process behavior.
Batches that deviate from normal operating conditions can be quickly identified in order to provide corrective action as required, saving time and resources.
Strengthening Quality Across Advanced Modalities
Radiance® supports in‑process monitoring across the full spectrum of advanced biologics and ATMP manufacturing. Whether teams are producing viral vectors, expanding therapeutic cells, or running vaccine or protein‑based processes, Radiance® provides a single, label‑free platform for measuring real‑time cellular performance. By standardizing on a single analytical platform across process development, analytical development, manufacturing, and QC, teams streamline tech transfer and comparability, reduce operational friction, and accelerate time to patients through more robust, regulatory‑aligned workflows.
By resolving whole‑cell functional signatures tied to cell vitality, potency, and stress response, Radiance® helps developers maintain tighter control over:
- Producer cell fitness and infection/transfection readiness in viral vector production
- Expansion potential, differentiation, and functional robustness in cell therapy manufacturing
- Transduction efficiency and vector titer and quality in gene therapy workflows
- Real-time cell health and viral titer analytics in vaccine development and manufacturing workflows
This unified analytical approach strengthens consistency, accelerates decision‑making, and supports more predictable outcomes across diverse manufacturing platforms.
A More Confident Path Forward
Radiance® equips biomanufacturing teams with real‑time, whole‑cell intelligence to accelerate decisions, minimize variability, tighten process control, and reliably produce high‑quality advanced biologics and ATMPs.
